PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8480292

[Epilepsy and physical activity].

K O Nakken
View original source ↗Export metadata ↓

Abstract

Physicians should encourage epileptic patients to participate in sporting activities to enhance their physical fitness, self-esteem and social integration. Since about 5% of the population with epilepsy run the risk of suffering seizures induced by exercise, advice on such activity should be given individually. The physician should have good insight into the patient's medical history and should be interested in, and know about the different kinds of sport. The risk of injuries connected to seizure must be weighed against the physical, psychological and social problems which may result from exclusion from sports.

Explore related subjects

EpilepsyExerciseHumansPhysical FitnessPhysician's RoleSelf ConceptEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K O Nakken. 1993-03-10. [Epilepsy and physical activity].. https://pubmed.ncbi.nlm.nih.gov/8480292/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Long-term seizure outcomes and factors associated with response to adjunctive everolimus in TSC-associated epilepsy.

BACKGROUND: Everolimus, a mechanistic target of rapamycin (mTOR) inhibitor, is increasingly used in tuberous sclerosis complex (TSC)-associated epilepsy; however, long-term real-world outcomes and factors associated with favorable response remain unclear. This study aimed to evaluate the long-term seizure outcomes of adjunctive everolimus and explore clinical factors associated with treatment response. METHODS: We retrospectively recruited 21 patients with active TSC-associated epilepsy receiving adjunctive everolimus and assessed seizure outcomes during follow-up. Clinical characteristics were compared between responders and non-responders at 1 year after treatment initiation. RESULTS: Over a median treatment duration of 72 months, responder rates ranged from 53.8% to 64.7%, and seizure-free rates ranged from 33.3% to 41.2%. Responders had fewer involved organ systems at baseline (median 3 vs. 4, p = 0.020) and lower anti-seizure medication burden (median 2 vs. 4, p = 0.045). Younger age at treatment initiation showed a trend toward improved response. CONCLUSION: Adjunctive everolimus was associated with sustained long-term seizure reduction in this real-world cohort. In exploratory analyses, fewer involved organ systems and fewer baseline ASMs were associated with favorable treatment response. These findings require validation in larger prospective cohorts.

Epilepsy↗